Participants 186 210 3
Helicobacter pylori (HP)
Participants 270 290 3
HP-infected patients
Participants 316 468 3
to evaluate a novel four-drug regimen (three antibiotics and a proton pump inhibitor (PPI)) for eradication of HP infection in treatment-naive patients.
Participants 477 637 7
Patients with a diagnosis of HP gastritis or peptic ulcer disease confirmed using endoscopy and stool antigen testing were eligible for inclusion in this study.
Participants 1696 1832 3
This open-label, prospective trial demonstrates that LOAD is a highly active regimen for the treatment of HP in treatment-naive patients
